A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays

2.8K views

⸱

DOI:

10.3791/64881

⸱

February 24th, 2023

 ,  ,  ,  ,  ,  ,  , 

In This Article

Summary

The present protocol describes methods for evaluating DNA damage repair proteins in patient-derived ovarian cancer organoids. Included here are comprehensive plating and staining methods, as well as detailed, objective quantification procedures.

Abstract

Immunofluorescence is one of the most widely used techniques to visualize target antigens with high sensitivity and specificity, allowing for the accurate identification and localization of proteins, glycans, and small molecules. While this technique is well-established in two-dimensional (2D) cell culture, less is known about its use in three-dimensional (3D) cell models. Ovarian cancer organoids are 3D tumor models that recapitulate tumor cell clonal heterogeneity, the tumor microenvironment, and cell-cell and cell-matrix interactions. Thus, they are superior to cell lines for the evaluation of drug sensitivity and functional biomarkers. Therefore, the ability to utilize immunofluorescence on primary ovarian cancer organoids is extremely beneficial in understanding the biology of this cancer. The current study describes the technique of immunofluorescence to detect DNA damage repair proteins in high-grade serous patient-derived ovarian cancer organoids (PDOs). After exposing the PDOs to ionizing radiation, immunofluorescence is performed on intact organoids to evaluate nuclear proteins as foci. Images are collected using z-stack imaging on confocal microscopy and analyzed using automated foci counting software. The described methods allow for the analysis of temporal and special recruitment of DNA damage repair proteins and colocalization of these proteins with cell-cycle markers.

Introduction

Ovarian cancer is the leading cause of death due to gynecologic malignancy. The majority of patients are treated with DNA-damaging drugs such as carboplatin, and those with homologous recombination repair (HRR)-deficient tumors can be given poly (ADP-ribose) polymerase (PARP) inhibitors1,2. However, most patients develop resistance to these therapies and die within 5 years of diagnosis. Dysregulation of the DNA damage response (DDR) has been associated with the development of ovarian cancer and both chemotherapy and PARP inhibitor resistance3. Thus, study of the DDR is imperative in und....

Access restricted. Please log in or start a trial to view this content.

Protocol

Tumor tissue and ascites were obtained after obtaining patient consent as part of a gynecologic oncology biorepository that was approved by the Washington University in St. Louis Institutional Review Board (IRB). Patients were included if they had advanced stage high-grade serous ovarian cancer (HGSOC). All procedures were performed at room temperature on the bench unless otherwise specified. All reagents were prepared at room temperature (unless otherwise indicated) and stored at 4 °C.

1. Organoid generation

  1. Generate the organoids following the previously published report20.

Access restricted. Please log in or start a trial to view this content.

Results

The presented protocol can successfully stain, visualize, and quantify nuclear DNA damage repair proteins in organoids. This technique was used to stain and evaluate PDOs both before and after irradiation. PDOs were exposed to 10 Gy of radiation and evaluated for the following biomarkers: ɣ-H2AX (Figure 1), a marker of DNA damage; RAD51 (Figure 2), a marker for HRR; 53BP1, a marker of NHEJ; RPA, a marker of replication stress (Figure 3

Access restricted. Please log in or start a trial to view this content.

Discussion

The DNA damage response plays an integral role in both the development of ovarian cancer and chemotherapy resistance. Therefore, a thorough understanding of DNA repair mechanisms is imperative. Here, a methodology is presented to study DNA damage repair proteins in 3D, intact organoids. A reproducible, reliable protocol is developed utilizing hallmark antibodies to evaluate DNA damage, homologous recombination, non-homologous end joining, and replication stress. Importantly, these methods are validated using genetically .......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

We are grateful for the guidance of Pavel Lobachevsky, PhD in establishing this protocol. We'd also like to acknowledge Washington University's School of Medicine in St. Louis's Department of Obstetrics and Gynecology and Division of Gynecologic Oncology, Washington University's Dean's Scholar Program, Gynecologic Oncology Group Foundation, and the Reproductive Scientist Development Program for their support of this project.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
1x phosphate buffered saline with calcium and magnesium (PBS++)Sigma14-040-133
1x phosphate buffered saline without calcium and magnesium (PBS)Fisher Scientific ICN1860454
Ant-53BP1 Antibody BD Biosciences612522diluted to 1:500 in staining buffer
Ant-Geminin Antibody Abcamab104306diluted to 1:200 in staining buffer
Anti-Geminin Antibody ProteinTech10802-1-APdiluted to 1:400 in staining buffer
Anti-RAD51 Antibody Abcamab133534diluted to 1:1000 in staining buffer
Anti-yH2AX Antibody Millipore-Sigma05-636diluted to 1:500 in staining buffer
Ant-phospho-RPA32 (S4/S8) AntibodyBethyl Laboratories A300-245A-Mdiluted to 1:200 in staining buffer
Bovine Serum Albumin (BSA)Fisher Scientific BP1605 100
Centrifuge; Sorvall St 16R CentrifugeThermo Scientific 75004240
Confocal Microscope, Leica SP5 confocal system DMI4000Leica 389584
Conical Tubes, 15 mLCorning 14-959-53A
Countess 3 FL Automated Cell Counter (Cell Counting Machine) Thermo Scientific AMQAF2000
Countess Cell Counting Chamber SlidesThermo Scientific C10228
Cover SlipLA ColorsAny clear nail polish will suffice
Cultrex RGF Basement Membrane Extract, Type 2 R&D Systems 3533-010-02Could probably use Matrigel or other BME Matrix 
DAPI Thermo Scientific  R37606NucBlue Fixed Cell ReadyProbes Reagent, Diluted in 1x PBS 
Glycine Fisher Scientific NC0756056
JCountProJCountProFor access to the software, Email: jcountpro@gmail.com 
Microcentrifuge Tubes Fisher Scientific 07-000-243
Nail Polish StatLabSL102450
Parafomraldehyde (PFA), 2% Electron Microscopy Sciences 157-4Dilute to 4% PFA in PBS++ to obtain 2% PFA
Permeabilization BufferMade in Lab0.2% X-100 Triton in PBS++ 
PipetteRainin17014382
Pipette Tips Rainin 17014967
ProLong Gold Antifade MountantThermo Scientific  P36930
Staining Buffer Made in Lab0.5% BSA, 0.15% Glycine, 0.1% X-100 Triton in PBS++ 
Thermo Scientific Nunc Lab-Tek II Chamber Slide System Thermo Scientific 12-565-8
Triton X-100Sigma-Alderich 11332481001
Trypan Blue Solution, 0.4%Thermo Scientific 15250061
TrypLE ExpressInvitrogen12604013animal origin-free, recombinant enzyme
X-RAD 320 Biological Irradiator Precision X-Ray Irradiation X-RAD320

References

  1. Lheureux, S., Gourley, C., Vergote, I., Oza, A. M. Epithelial ovarian cancer. Lancet Oncology. 393 (10177), 1240-1253 (2019).
  2. Tew, W. P., et al. PARP inhibitors in the management of ovarian cancer: ASCO guideline. Journal of Clinical Oncology. 38 (30), 3468-3493 (2....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Immunofluorescence AssayConfocal MicroscopyPatient Derived Organoids3D Cell CultureDNA Damage ResponseProtein LocalizationBiomarker EvaluationGamma H2AX